Evidence map›Paper›PMID 32785038›Full record

ArticlePharmaceutics2020

The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis.

Ui Seok Kim, Jin Woo Park, Eon Sub Park, Joon Seok Bang, Tae Woo Jung, Dong-Seok Kim, A M Abd El-Aty, Jong Hyuk Lee, Ji Hoon Jeong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ui Seok KimDepartment of Pharmacology, College of Medicine, Chung-Ang University, Seoul 06974, Korea.
Jin Woo ParkDepartment of Pharmacology, College of Medicine, Chung-Ang University, Seoul 06974, Korea.
Eon Sub ParkDepartment of Pathology, College of Medicine, Chung-Ang University, Seoul 06974, Korea.
Joon Seok BangCollege of Pharmacy, Sookmyung Women's University, Seoul 04310, Korea.
Tae Woo JungDepartment of Pharmacology, College of Medicine, Chung-Ang University, Seoul 06974, Korea.
Dong-Seok KimDepartment of Biochemistry, College of Medicine, Chung-Ang University, Seoul 06974, Korea.
A M Abd El-AtyDepartment of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.
Jong Hyuk LeeDepartment of Pharmaceutical Engineering, College of Life and Health Science, Hoseo University, Asan 31499, Korea.ORCID 0000-0002-9932-8879
Ji Hoon JeongDepartment of Pharmacology, College of Medicine, Chung-Ang University, Seoul 06974, Korea.ORCID 0000-0001-8257-403X
Chung-Ang University · KRCairo University · EGHoseo University · KRSookmyung Women's University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to restore the skin barrier function from atopic dermatitis (AD) via treatment with leucine-rich glioma inactivated 3 (LGI3) peptide. Male NC/Nga mice (7 weeks, 20 g) were randomly allocated into three groups (control, AD, and LGI3 group). After induction of AD skin lesions with

Indexed as

atopic dermatitisfilaggrinkeratosisleucine-rich glioma inactivated 3 (LGI3) peptideskin barrier

Identifiers

PMID32785038
PMCPMC7463480
OpenAlexW3048353130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.